ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO197

Atherosclerosis Is Associated with a Reduction in the Density of Renal Microcirculation

Session Information

Category: Hypertension

  • 1103 Vascular Biology and Dysfunction

Authors

  • Hueso, Miguel, Hospital Universitari de Bellvitge, Barcelona, Spain
  • Casas Parra, Angela Isabel, Hospital Universitari de Bellvitge, Barcelona, Spain
  • Navarro, Estanislao, IDIBELL, L'Hospitalet, Spain
  • Bolanos, Nuria, IDIBELL, L'Hospitalet, Spain
  • Varela, Cristian, IDIBELL, L'Hospitalet, Spain
  • Ripoll, Elia, Laboratory of Experimental Nephrology, IDIBELL. Hospital Universitari de Bellvitge, Barcelona, Spain
  • Grinyo, J., Hospital Universitari de Bellvitge, Barcelona, Spain
  • Cruzado, Josep M., Hospital Universitari de Bellvitge, Barcelona, Spain
  • Torras, Juan, Hospital Universitari de Bellvitge, Barcelona, Spain
Background

Cardiovascular disease is increased in renal diseases but the role of renal microcirculation in the development of atherosclerosis is unknown. CD40/CD40L signaling has a critical role in atherosclerosis and CD40 silencing reduces their progression. In addition, CD40/CD40L signaling may lead to blood vessel dysfunction and occlusion. Thus, we used the CD40-silenced ApoE-/- model of atherosclerosis to study the interplay between atherosclerosis and renal microcirculation.

Methods

CD40 was silenced with a specific siRNA in the ApoE-/- mouse model during 16 weeks. We administrated scrambled siRNA (SC) or PBS (vehicle) as controls. Endothelium was identified by immunohistochemistry using PECAM-1 antibody (platelet endothelial cell adhesion molecule-1). Kidneys were isolated from 24 weeks-old mice. The density of peritubular capillaries was quantified using ImageJ v1.48 and expressed as a proportion. The extension of atherosclerotic lesions was quantified in HE staining from ascending aortas.

Results

SiRNA-CD40 treated ApoE-/- mice reduced the extension of atherosclerotic lesions in ApoE-/- mice. Furthermore, a decrease of renal microcirculation density was observed in this experimental model of atherosclerosis (siRNA-CD40, n=9, 4.5±2.2%; SC, n=4, 2.1±0.8 %; Vehicle, n=9, 2.0±1.4%, p<0.0001). No differences in serum creatinine was detected (siRNA-CD40: 0.6±0.18 mg/dL; SC: 0.54±0.2 mg/dL; Vehicle: 0.51±0.3 mg/dL, p=ns).

Conclusion

A reduction in peritubular capillaries was associated with severe atherosclerosis lesions. This data provide structural basis of renal disease in patients with atherosclerosis.